IVDR Classification | The Complete 2026 Guide to Rules, Classes A–D, and Next Steps

IVDR classification decides how much proof your diagnostic test needs before it can carry a CE mark. Get it right, and you plan the correct budget, timeline, and review route. Get it wrong, and you may lose months to rework.

Under IVDR 2017/746, you no longer match your device to a fixed list. Instead, you apply seven rules and place the device in Class A, B, C, or D. This guide explains each rule in plain English, with examples, 2026 updates, and clear next steps. A short FAQ at the end answers the most common questions.

What Is IVDR Classification?

IVDR classification is a risk-based system for sorting in vitro diagnostic (IVD) devices. An IVD is a test, reagent, instrument, or software that examines samples from the human body, such as blood or urine, to give medical information.

The rules sit in Annex VIII of Regulation (EU) 2017/746. They create four risk classes: A is the lowest risk, and D is the highest. The class depends on the harm a wrong result could cause to a patient or to public health.

The manufacturer sets the class, not the notified body. However, a notified body will check your decision during review. You must therefore document your reasoning clearly.

Why IVDR Classification Matters for CE Marking

Your class controls the conformity assessment route. In simple terms, it decides who reviews your device and how deeply.

• Class A (non-sterile): you can self-declare conformity without a notified body.
• Class A sterile, B, C, and D: a notified body must review your device.
• Class D: expect the strictest path, including extra batch checks and expert scrutiny for new technologies.

Class also drives cost, timeline, and the amount of performance evaluation data you must collect. A higher class means more evidence and more review time.

In short, ivdr classification is the first big decision in your CE marking plan. Every later step builds on it. NKB's EU qualification and classification service helps teams lock this decision early.

The Four IVDR Risk Classes at a Glance

This table of ideas gives you the big picture before we look at each rule.

• Class A: lowest risk. Examples include general lab buffers and non-critical accessories.
• Class B: low to moderate risk. Class B is also the fallback class for devices that no other rule captures.
• Class C: high individual risk. Many tests that guide serious clinical decisions fall here.
• Class D: highest risk. These tests protect blood supplies or screen for the most dangerous infectious agents.

The IVDD, the old directive, worked from lists. The IVDR works from rules. Therefore, most diagnostic tests now land in Class B, C, or D, and few remain in Class A.

How the IVDR Classification Rules Work

Before you read the seven rules, you need to know two core principles. Both appear in the implementing rules of Annex VIII.

Start With the Intended Purpose

The intended purpose is what you, the manufacturer, say the device does. Your label, instructions for use, and promotional material all define it. As MedTech Dive explains, these documents dictate the class.

For example, a syphilis test for donor screening falls in Class D. A syphilis test for diagnosing an individual falls in Class C. The marker is the same, but the purpose differs.

Apply Every Rule and Use the Highest Class

You must check all seven rules for every device. If more than one rule fits, the highest class wins. The official guidance, MDCG 2020-16, repeats this point and gives worked examples. You can read a clear summary in OpenRegulatory's MDCG 2020-16 explainer.

Tip: write a one-page classification fact sheet. List each rule, quote its wording, and explain why it applies or does not.

The Seven IVDR Classification Rules Explained

Here is each rule in everyday language. Use it as a guide, not as a replacement for Annex VIII.

Rule 1: Class D for the Most Dangerous Agents

Rule 1 covers tests that detect transmissible agents in blood, cells, tissues, or organs used for transfusion or transplant. It also covers agents that cause life-threatening disease with a high risk of spread. These devices are Class D.

Rule 2: Blood Grouping and Tissue Typing

Rule 2 covers blood grouping and tissue typing tests. Most are Class C. However, tests for the ABO, Rhesus, Kell, Kidd, and Duffy systems are Class D, because errors can cause fatal transfusion reactions.

Rule 3: Class C for Many Clinical Decisions

Rule 3 is the longest rule. It places devices in Class C when a wrong result could seriously harm the patient. Examples include tests for sexually transmitted agents, cancer screening and staging, human genetic testing, and congenital disorder screening. Companion diagnostics also fall here. These tests decide whether a patient can receive a specific drug.

Rule 4: Self-Testing and Near-Patient Testing

Most self-testing devices are Class C. A few exceptions drop to Class B, such as pregnancy, fertility, and cholesterol tests. A self-test for HIV stays in Class D, because Rule 1 gives the higher class. Near-patient tests follow the rule that matches their purpose.

Rules 5, 6, and 7: Class A and Class B

• Rule 5: products for general laboratory use, many accessories, instruments, and specimen receptacles are Class A.
• Rule 6: devices not covered by other rules are Class B.
• Rule 7: control materials without an assigned value are Class B.

The IVDR Classification Process, Step by Step

Use this simple workflow for any new IVD.

1. Confirm the product is an IVD. Check qualification first. NKB's article on borderline products explains how qualification differs from classification.
2. Write the intended purpose. Include the analyte, sample type, user, setting, and clinical use.
3. Read the implementing rules. They cover accessories, software, and combinations.
4. Test all seven rules. Do not stop at the first match.
5. Select the highest class. Record why each other rule fails.
6. Review with an expert. A second opinion catches blind spots.
7. Choose your conformity route. Then plan evidence, quality system, and notified body contact.

Treat the result as a living record. If your intended purpose changes, repeat the exercise.

Real-World Device Examples

Examples make the rules easier to remember.

• HIV blood screening test: Class D (Rule 1).
• ABO blood group reagent: Class D (Rule 2).
• Diagnostic syphilis test for patients: Class C (Rule 3).
• Companion diagnostic for a cancer drug: Class C (Rule 3).
• Home pregnancy test: Class B (Rule 4 exception).
• Home test for another condition: usually Class C (Rule 4).
• General lab buffer or specimen container: Class A (Rule 5).

Combinations need care. According to the MDCG guidance, an analyzer that runs an ELISA test is Class A, while the reagents can be Class B, C, or D depending on their purpose. RegDesk's guidance summary walks through more cases.

IVDR Classification for Software and Accessories

Software raises many questions. Independent IVD software gets its own class under Annex VIII. It does not inherit the class of the analyzer that happens to run it.

However, software that drives or influences another device takes the class of that device. Accessories follow their own intended purpose, and the implementing rules explain how to treat them.

Because software and combination products often cause disputes, document your logic in detail. Reviewers read these sections closely.

IVDR Classification vs. IVDD: What Changed?

Under the IVDD, most IVDs were self-declared. Only devices on Annex II List A, List B, and self-testing needed a notified body.

The IVDR flips that picture. Rules replace lists, and nearly every device except non-sterile Class A needs notified body review. As a result, many products that once self-certified now need an audit.

Therefore, do not copy your old IVDD category into your IVDR file. Classify again from scratch using Annex VIII.

IVDR Classification Updates and Deadlines in 2026

Three updates matter this year.

First, the guidance changed. MDCG 2020-16 Revision 4 appeared in March 2025. According to QbD Group, it reclassified SARS-CoV-2 detection devices, which no longer sit in Class D. It also noted that classes for some infectious agents can change when the epidemiological situation changes.

Second, the transition period still runs. Under the extended timeline in the European Commission's IVDR update, eligible legacy devices may stay on the market until 31 December 2027 (Class D), 2028 (Class C), or 2029 (Class B and sterile Class A). Strict conditions apply, including quality system and notified body application milestones. The Class D and Class C application dates have already passed, while the Class B and sterile Class A application date falls in May 2027.

Third, reform is on the table. The Commission floated a simplification proposal in December 2025. A proposal is not law, so current rules apply. Track the Commission's medical devices page and see NKB's MDR and IVDR transition support.

Common Classification Mistakes to Avoid

Manufacturers repeat the same errors:

• Vague intended purpose. Broad claims push the device into a higher class.
• Stopping at one rule. You must test every rule.
• Copying the IVDD class. The systems differ.
• Ignoring accessories and software. Each may need its own class.
• Mixing up qualification and classification. First decide whether the product is an IVD. Then classify it.
• No written rationale. Reviewers want to see your logic, not only your result.

The Johner Institute also shows how careful wording can avoid an unnecessarily high class. Never narrow your claims in a way that misleads users, though. Accuracy comes first.

When to Get Expert Help With IVDR Classification

Some cases deserve a second pair of eyes. Consider help when your device includes software, detects several markers, serves as a companion diagnostic, or sits near the border between two classes.

An experienced consultant can also help you plan what comes next: performance evaluation, technical documentation, a notified body strategy, and ISO 13485 quality system work.

NKB Regovanta supports IVD manufacturers across Class A to D, including self-testing and companion diagnostics. Explore the IVDR services page, the IVDR performance evaluation service, or the IVD industry page. You can also read related guides on IVDR transition planning and Class D verification. Ready to talk? Book a consultation.

What Regulatory Communities Discuss

Regulatory professionals swap practical tips online. Communities such as r/regulatoryaffairs and r/medicaldevices often cover classification doubts, notified body timing, and IVDR transition worries.

Use them to learn how peers think. However, treat comments as opinion. Always confirm answers against the regulation and MDCG guidance.

IVDR Classification FAQ

What is IVDR classification?

IVDR classification is the system that sorts IVD devices into Class A, B, C, or D based on risk. You apply seven rules in Annex VIII of Regulation (EU) 2017/746. The class decides your conformity assessment route and evidence level.

How many IVDR classes are there?

There are four classes. Class A is the lowest risk, Class B is low to moderate, Class C is high individual risk, and Class D is the highest risk. Most diagnostic tests now fall in Classes B, C, or D.

Which IVDs are Class D?

Class D covers tests that detect dangerous transmissible agents in blood, cells, or organs for transfusion or transplant. It also covers tests for life-threatening agents with a high risk of spread, plus ABO, Rhesus, Kell, Kidd, and Duffy blood group tests.

Is a self-test always Class C?

No. Most self-tests are Class C, but pregnancy, fertility, and cholesterol tests are Class B. A self-test for a Rule 1 agent, such as HIV, is Class D because the higher class applies.

Does a Class A IVD need a notified body?

Usually no. Non-sterile Class A devices can use self-declaration. Sterile Class A devices need a notified body.

Is IVDR classification the same as MDR classification?

No. The MDR uses a different rule set for medical devices in Annex VIII of Regulation (EU) 2017/745. The IVDR has seven rules built around the risk of a wrong test result.

Who decides my IVD class?

You, the manufacturer, decide first. The notified body then reviews your reasoning. In disputes, national authorities or the European Commission can decide.

Can I get help with IVDR classification?

Yes. Many manufacturers use a regulatory consultant to review intended purpose, apply the rules, and plan evidence. Choose a partner with IVD experience and ask for a written classification rationale.

Conclusion: Make Classification Your First Strong Decision

IVDR classification shapes every part of your CE marking journey. Start with a precise intended purpose, test all seven rules, and keep a clear written rationale. Then match your evidence plan to the class you select.

With deadlines moving and notified body capacity limited, early clarity saves time and money. Share your device details with NKB Regovanta through the contact page to get a practical IVDR roadmap.